Catheter Precision, Inc. Common Stock (AMEX:VTAK) reported quarterly losses of $(1.70) per share which missed the analyst consensus estimate of $(0.11) by 1445.45 percent. This is a 95.55 percent increase over losses of $(38.19) per share from the same period last year. The company reported quarterly sales of $226.000 thousand which missed the analyst consensus estimate of $1.700 million by 86.71 percent. This is a 135.42 percent increase over sales of $96.000 thousand the same period last year.